You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dual Mutation

Showing 1 - 25 of 5,323
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV-1 Infection Trial in Caba, Rosario (Dolutegravir plus lamivudine)

Withdrawn
  • HIV-1 Infection
  • Dolutegravir plus lamivudine
  • Caba, Buenos Aires, Argentina
  • +1 more
Apr 5, 2022

PIK3CA Mutation-Related Tumors Trial in Shanghai (WX390)

Completed
  • PIK3CA Mutation-Related Tumors
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Nov 9, 2023

Advanced Non Small Cell Lung Cancer Trial in Changsha (Toripalimab combination with platinum-containing dual-drug chemo)

Recruiting
  • Advanced Non Small Cell Lung Cancer
  • Toripalimab combination with platinum-containing dual-drug chemotherapy
  • Changsha, Hunan, China
    Hunan Provincal Tumor Hospital
Dec 28, 2021

Ovarian Cancer Trial in Worldwide (VS-6766, VS-6766 and Defactinib)

Recruiting
  • Low Grade Ovarian Serous Adenocarcinoma
  • Ovarian Cancer
  • avutometinib (VS-6766)
  • avutometinib (VS-6766) and Defactinib
  • Scottsdale, Arizona
  • +46 more
Dec 29, 2022

Non Small Cell Lung Cancer, KRAS Activating Mutation Trial in Worldwide (VS-6766, VS-6766 and Defactinib)

Recruiting
  • Non Small Cell Lung Cancer
  • KRAS Activating Mutation
  • avutometinib (VS-6766)
  • avutometinib (VS-6766) and Defactinib
  • Duarte, California
  • +44 more
Dec 22, 2022

Ischemic Stroke, Transient Ischemic Attack Trial in Singapore (Genetic testing)

Not yet recruiting
  • Ischemic Stroke
  • Transient Ischemic Attack
  • Genetic testing
  • Singapore, Singapore
    Singapore General Hospital
Mar 9, 2023

Glioma Trial in United States (AG881)

Active, not recruiting
  • Glioma
  • Los Angeles, California
  • +8 more
May 16, 2022

HER2, Colorectal Cancer Trial (Disitamab Vedotin Combined With Fruquintinib)

Not yet recruiting
  • HER2
  • Colorectal Cancer
  • Disitamab Vedotin Combined With Fruquintinib
  • (no location specified)
Dec 21, 2022

Single Photon Emission Computed Tomography/Computed Tomography

Not yet recruiting
  • Brain Glioma
  • SPECT with pentavalent 99mTc DMSA
  • (no location specified)
Oct 23, 2022

Merkel Cell Carcinoma Trial in Wollstonecraft (Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination)

Not yet recruiting
  • Merkel Cell Carcinoma
  • Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination
  • Wollstonecraft, New South Wales, Australia
    Melanoma Institute Australia
Nov 21, 2023

NSCLC, EGF-R Positive NSCLC Trial in Wuxi (Parimparib, Chemotherapy drug, Targeted Therapy Agent)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • EGF-R Positive Non-Small Cell Lung Cancer
  • Wuxi, Jiangsu, China
    Affiliated Hospital of Jiangnan University
Jan 30, 2023

Recurrent and Metastatic CRC After Surgery by Multi-omics

Not yet recruiting
  • Colorectal Cancer Metastatic
  • no intervention
  • (no location specified)
Aug 11, 2022

Familial Mediterranean Fever Trial in Thessaloníki

Recruiting
  • Familial Mediterranean Fever
    • Thessaloníki, Municipality Of Pavlou Mela, Greece
      Papageorgiou General Hospital
    Sep 11, 2023

    Solid Tumors Harboring a BRAF V600 Mutation Trial in Worldwide (LGX818, MEK162, LEE011)

    Active, not recruiting
    • Solid Tumors Harboring a BRAF V600 Mutation
    • Tampa, Florida
    • +22 more
    Mar 16, 2022

    Inherited Bone Marrow Failure Syndrome, Familial Platelet Disorder With Predisposition to Myeloid Malignancies Trial run by the

    Not yet recruiting
    • Inherited Bone Marrow Failure Syndrome
    • Familial Platelet Disorder With Predisposition to Myeloid Malignancies
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 20, 2023

    Isocitrate Dehydrogenase Gene Mutation Trial in Spain, United States (HMPL-306)

    Recruiting
    • Isocitrate Dehydrogenase Gene Mutation
    • Santa Monica, California
    • +8 more
    Feb 22, 2022

    Non Small Cell Lung Cancer Metastatic Trial in Worldwide (Osimertinib, Bevacizumab)

    Active, not recruiting
    • Non Small Cell Lung Cancer Metastatic
    • Dublin, Ireland
    • +24 more
    Aug 23, 2022

    Natural History of Pompe Disease

    Recruiting
    • Glycogen Storage Disease Type II, Adult
      • Garches, Hauts-de-Seine, France
        Hôpital Raymond Poincaré
      Apr 20, 2022

      Malaria, Anemia Trial in Cove (Bed nets)

      Active, not recruiting
      • Malaria
      • Anemia
      • Bed nets
      • Cove, Benin
        Manfred Accrombessi
      Aug 23, 2022

      Advanced Solid Tumor (Phase 1), Pancreatic Adenocarcinoma, Malignant Melanoma (Cutaneous) Trial in United States (IMM-1-104)

      Recruiting
      • Advanced Solid Tumor (Phase 1)
      • +4 more
      • Duarte, California
      • +4 more
      Feb 2, 2023

      Mitochondrial Dysfunctions Driving Insulin Resistance

      Recruiting
      • Mitochondrial Myopathies
      • +2 more
        • Copenhagen, Denmark
          Rigshospitalet
        Oct 16, 2023

        Non Small Cell Lung Cancer Trial (Toripalimab, Toripalimab mimetic ())

        Not yet recruiting
        • Non Small Cell Lung Cancer
        • (no location specified)
        Feb 23, 2021

        Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

        Active, not recruiting
        • Advanced Breast Cancer
        • +2 more
        • Talazoparib Tosylate
        • Stanford, California
          Stanford University Hospitals and Clinics
        Nov 16, 2022

        Cystic Fibrosis (CF) Trial in Worldwide (Galicaftor, Placebo, Navocaftor)

        Active, not recruiting
        • Cystic Fibrosis (CF)
        • Mobile, Alabama
        • +46 more
        Oct 20, 2022

        Prevention of Chemo-induced Myelosuppression Trial in Worldwide (ALRN-6924, TAC (doxorubicin 50 mg/m2; cyclophosphamide 500

        Recruiting
        • Prevention of Chemotherapy-induced Myelosuppression
        • ALRN-6924
        • TAC (doxorubicin 50 mg/m2; cyclophosphamide 500 mg/m2; docetaxel 75 mg/m2)
        • Tamarac, Florida
        • +14 more
        Jan 31, 2023